Dave Fornell, DAIC Editor

Dave Fornell, editor of DAIC Magazine

The Heart Rhythm Society’s 36th Annual Scientific Sessions, May 13-16, 2015 in Boston, will offer the latest clinical data and new technology updates in electrophysiology (EP). These include new information on leadless pacing, the impact of wireless remote device monitoring, the latest advances in atrial fibrillation management and shockless ICD implant evaluations. 

View the list of the HRS late-breaking trial presentations

One of the key technology trends I have seen in healthcare in the past year is the mass proliferation of consumer-grade wearable health monitoring devices and their integration with smartphone technology. These devices and their expected impact on healthcare and physician patient engagement were among the hottest topics at the American College of Cardiology (ACC) and the Healthcare Information and Management Systems Society (HIMSS) meetings earlier this year. HRS also has sessions that will discuss this evolution in patient involvement in their own care, including a “body computing” display at the EPicenter, Booth 535 on the expo floor. This area will show how digital health is impacting medicine with the convergence of sophisticated diagnostic sensors, innovative mobile applications and a powerful technology infrastructure.

HRS 2015 includes more than 250 educational sections and 130 exhibitors. HRS plans to highlight some of the key educational sessions with video posted online within 24 hours of the sessions. This offers a unique opportunity for medical professionals who are unable to attend the meeting, or those with scheduling conflicts, to view a selection of the state-of-the-art presentations. View the list of webcast presentations.

Below are some key technologies that will be discussed in sessions and on the expo floor.


Related Content

News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
Subscribe Now